REVB - REVELATION BIOSCIENCES, INC.
1.24
-0.010 -0.806%
Share volume: 36,194
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$1.25
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 09-23-2024 | 09-23-2024 | 11-08-2024 | 03-06-2025 | 05-08-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 1.902 M | 2.522 M | 1.797 M | 1.754 M | 2.095 M | 1.943 M | 2.572 M | |
| Selling general and admin | 1.185 M | 1.127 M | 965.705 K | 1.148 M | 1.236 M | 1.020 M | 1.607 M | |
| Research and development | 717.582 K | 1.395 M | 830.981 K | 605.504 K | 858.830 K | 922.857 K | 964.190 K | |
| Total expenses | 1.902 M | 2.522 M | 1.797 M | 1.754 M | 2.095 M | 1.943 M | 2.572 M | |
| 32.61% | -28.77% | -2.38% | 19.45% | -7.25% | 32.35% | |||
| Operating income | -1.902 M | -2.522 M | -1.797 M | -1.754 M | -2.095 M | -1.943 M | -2.572 M | |
| Ebit | -2.681 M | -8.390 M | -2.242 M | -1.726 M | -2.051 M | -1.907 M | -2.511 M | |
| Pretax income | -2.681 M | -8.390 M | -2.242 M | -1.726 M | -2.051 M | -1.907 M | -2.511 M | |
| 212.89% | -73.28% | -23.01% | 18.85% | -7.02% | 31.66% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.681 M | -8.390 M | -2.242 M | -1.726 M | -2.051 M | -1.907 M | -2.511 M | |
| -212.89% | 73.28% | 23.01% | -18.85% | 7.02% | -31.66% |